Impact of diabetes mellitus on survival in patients with end-stage renal disease: a three-year follow-up.
OBJECTIVE
To assess the impact of diabetes mellitus (DM) on clinical outcome in patients with end-stage renal disease (ESRD) on a 3-year follow-up.


METHODS
58 ESRD patients were divided into 2 groups according to the presence of DM. We analyzed following end points: death, cardiac arrest, myocardial infarction, stroke, hospitalizations due to cardiovascular causes, revascularization, and combined end point.


RESULTS
Among diabetics, 14 (77.8%) had significant atherosclerotic changes, in the group without DM only 8 (38.1%), p = 0.01. In the group without DM, 14 (46.7%) patients reached combined end point, while in the group with DM 16 (53.3%) patients, p = 0.0013. There were no statistical differences in mortality (p = 0.423).


CONCLUSIONS
Survival of hemodialyzed diabetic patients is not inferior to nondiabetics; however, morbidity is significantly higher due to adverse cardiac events.
Department of Cardiology, Medical University, ul. Skłodowska-Curie 24A, Bialystok, Poland. walkaz@poczta.fm
Anna
A
Tomaszuk-Kazberuk
Hanna
H
Bachorzewska-Gajewska
Jolanta
J
Malyszko
Jacek
J
Malyszko
Michal
M
Mysliwiec
Wlodzimierz J
WJ
Musial
D000368:Aged; D002318:Cardiovascular Diseases / Q000209:etiology; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000401:mortality*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007676:Kidney Failure, Chronic / Q000401:mortality*; D008875:Middle Aged; D009017:Morbidity; D006435:Renal Dialysis